{"slideshow_credits": null, "snippet": "Twitter Chief\u2019s Exit Sparks Deal Speculation | I.M.F. Pulls Team From Greece Bailout Talks | Murdoch to Hand Over Media Empire to Sons | Axovant\u2019s Market Debut Renews Biotech Bubble Worries", "abstract": "Twitter Chief\u2019s Exit Sparks Deal Speculation | I.M.F. Pulls Team From Greece Bailout Talks | Murdoch to Hand Over Media Empire to Sons | Axovant\u2019s Market Debut Renews Biotech Bubble Worries", "section_name": "Blogs", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"firstname": "Dealbook", "role": "reported", "rank": 1, "organization": ""}], "original": "By DEALBOOK"}, "web_url": "http://news.blogs.nytimes.com/2015/06/12/morning-agenda-twitter-chiefs-exit-sparks-deal-speculation/", "lead_paragraph": null, "headline": {"main": "Morning Agenda: Twitter Chief&#8217;s Exit Sparks Deal Speculation", "kicker": "News"}, "_id": "557ac00b38f0d82bd01b5238", "word_count": "1880", "multimedia": [], "pub_date": "2015-06-12T07:16:51Z", "source": "The New York Times", "news_desk": null, "keywords": [{"name": "persons", "value": "Bain, Adam", "rank": "1"}, {"name": "persons", "value": "Costolo, Dick", "rank": "2"}, {"name": "persons", "value": "Dorsey, Jack", "rank": "3"}, {"name": "persons", "value": "Murdoch, James R", "rank": "4"}, {"name": "persons", "value": "Murdoch, Lachlan", "rank": "5"}, {"name": "persons", "value": "Murdoch, Rupert", "rank": "6"}, {"name": "persons", "value": "Noto, Anthony J", "rank": "7"}, {"name": "glocations", "value": "Greece", "rank": "1"}, {"name": "organizations", "value": "Axovant Sciences Ltd.", "rank": "1"}, {"name": "organizations", "value": "Fox Entertainment Group Inc", "rank": "2"}, {"name": "organizations", "value": "GlaxoSmithKline PLC", "rank": "3"}, {"name": "organizations", "value": "International Monetary Fund", "rank": "4"}, {"name": "organizations", "value": "Twitter", "rank": "5"}, {"name": "subject", "value": "Alzheimer's Disease", "rank": "1"}, {"name": "subject", "value": "Venture Capital", "rank": "11"}, {"name": "subject", "value": "Appointments and Executive Changes", "rank": "2"}, {"name": "subject", "value": "Banking and Financial Institutions", "rank": "3"}, {"name": "subject", "value": "Biotechnology and Bioengineering", "rank": "4"}, {"name": "subject", "value": "European Sovereign Debt Crisis (2010- )", "rank": "5"}, {"name": "subject", "value": "Hedge Funds", "rank": "6"}, {"name": "subject", "value": "Initial Public Offerings", "rank": "7"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": "8"}, {"name": "subject", "value": "Regulation and Deregulation of Industry", "rank": "9"}, {"name": "subject", "value": "Shareholder Rights and Activism", "rank": "10"}], "blog": [], "subsection_name": null, "type_of_material": "Blog"}